These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30151918)

  • 21. Diabetes mellitus and the exocrine pancreas.
    Gorelick FS
    Yale J Biol Med; 1983; 56(4):271-5. PubMed ID: 6367237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulatory effect of secretin on pancreatic polypeptide in diabetic patients.
    Toyota T; Koizumi M; Kai Y; Miura M; Umetsu M; Suzuki S; Goto Y
    Endocrinol Jpn; 1980 Apr; 27(2):145-7. PubMed ID: 6997022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of treatment of type 2 (insulin independent) diabetes mellitus on plasma concentrations of pancreatic polypeptide and glucagon.
    Berger D; Floyd JC; Pek SB
    Diabetologia; 1981 Aug; 21(2):120-5. PubMed ID: 7021284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed?
    Hardt PD; Brendel MD; Kloer HU; Bretzel RG
    Diabetes Care; 2008 Feb; 31 Suppl 2():S165-9. PubMed ID: 18227480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pancreatic infringement exocrine and endocrine in cystic fibrosis].
    Kessler L; Abély M
    Arch Pediatr; 2016 Dec; 23(12S):12S21-12S32. PubMed ID: 28231890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic diabetes mellitus.
    Sjoberg RJ; Kidd GS
    Diabetes Care; 1989; 12(10):715-24. PubMed ID: 2693011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the exocrine pancreas in the male Zucker diabetic fatty rat model of type 2 diabetes mellitus following 3 months of treatment with sitagliptin.
    Forest T; Holder D; Smith A; Cunningham C; Yao X; Dey M; Frederick C; Prahalada S
    Endocrinology; 2014 Mar; 155(3):783-92. PubMed ID: 24424056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure and function of the exocrine pancreas in patients with type 1 diabetes.
    Alexandre-Heymann L; Mallone R; Boitard C; Scharfmann R; Larger E
    Rev Endocr Metab Disord; 2019 Jun; 20(2):129-149. PubMed ID: 31077020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing diabetes due to diseases of the exocrine pancreas to type 1 and type 2 diabetes using propensity score matching.
    Lanzinger S; Karges W; Merger S; Laimer M; Lück U; Wagner C; Milek K; Holl RW;
    Pancreatology; 2020 Jul; 20(5):860-866. PubMed ID: 32620406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic effects of diesel exhaust particles in mice with type 1 diabetes mellitus.
    Nemmar A; Al-Salam S; Beegam S; Yuvaraju P; Yasin J; Ali BH
    Cell Physiol Biochem; 2014; 33(2):413-22. PubMed ID: 24556638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peculiarities of diabetes mellitus course in chronic pancreatitis].
    Vinokurova LV; Drozdov VN; Berezina OI; Shuliat'ev IS; Varvanina GG; Nemezhinskiĭ VI
    Eksp Klin Gastroenterol; 2011; (7):59-63. PubMed ID: 22364001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of Pancreatic Exocrine Diseases on the β-Cell and Glucose Metabolism-A Review with Currently Available Evidence.
    Ciochina M; Balaban DV; Manucu G; Jinga M; Gheorghe C
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
    Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
    Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes mellitus secondary to chronic pancreatitis.
    Larsen S
    Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to insulin treatment and survival in 104 cats with diabetes mellitus (1985-1995).
    Goossens MM; Nelson RW; Feldman EC; Griffey SM
    J Vet Intern Med; 1998; 12(1):1-6. PubMed ID: 9503353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetes mellitus due to exocrine pancreatic diseases].
    Tanaka K; Iwamoto Y
    Nihon Rinsho; 2006 Sep; Suppl 3():69-72. PubMed ID: 17022502
    [No Abstract]   [Full Text] [Related]  

  • 37. Pancreatic disorders and diabetes mellitus.
    Meisterfeld R; Ehehalt F; Saeger HD; Solimena M
    Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S7-S12. PubMed ID: 18777459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease?
    Ewald N; Bretzel RG
    Eur J Intern Med; 2013 Apr; 24(3):203-6. PubMed ID: 23375619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatogenic diabetes: special considerations for management.
    Cui Y; Andersen DK
    Pancreatology; 2011; 11(3):279-94. PubMed ID: 21757968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
    Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.